Peripheral Intravascular Ultrasound (IVUS) Catheter Market Size, Share, Growth, and Industry Analysis, By Type (IVUS as Stand-alone Procedure,Balloon Angioplasty with IVUS), By Application (Hospitals,Other), Regional Insights and Forecast to 2035

Peripheral Intravascular Ultrasound (IVUS) Catheter Market Overview

The global Peripheral Intravascular Ultrasound (IVUS) Catheter Market is forecast to expand from USD 400.68 million in 2026 and is expected to reach USD 2335.84 million by 2035, growing at a CAGR of 21.64% over the forecast period.

The Peripheral Intravascular Ultrasound (IVUS) Catheter Market is expanding as vascular specialists increasingly use intravascular imaging to characterize peripheral vessel anatomy, evaluate plaque morphology, measure luminal dimensions, optimize device selection, and assess treatment results. IVUS as Stand-alone Procedure accounts for approximately 58% of product demand, supported by growing clinical emphasis on detailed vessel assessment before and after peripheral interventions and increasing utilization of image-guided treatment strategies.

The United States remains a major adoption center for peripheral IVUS catheters because of its established interventional vascular infrastructure, large hospital network, growing peripheral artery disease treatment volume, and access to advanced catheter-based imaging technologies. The country accounts for approximately 41% of global procedure-related demand, with hospitals increasingly integrating IVUS into peripheral vascular workflows to support lesion assessment, vessel sizing, treatment planning, and post-procedure evaluation.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Market Driver: Increasing adoption of image-guided peripheral intervention influences approximately 44% of market expansion as clinicians seek more precise vessel measurement, lesion characterization, treatment planning, and procedural assessment than angiography alone can provide.
• Major Market Restraint: Procedure-related equipment and workflow requirements affect approximately 23% of adoption constraints, particularly where healthcare facilities have limited intravascular imaging infrastructure, trained personnel, or procedural volumes sufficient to support routine utilization.
• Emerging Trends: Higher-resolution catheter imaging and automated measurement capabilities influence approximately 37% of technology-development priorities as clinicians seek faster vessel assessment, improved image interpretation, and more consistent procedural decision support.
• Regional Leadership: North America accounts for approximately 46% of global demand, supported by established interventional vascular care, advanced hospital infrastructure, strong physician familiarity with intravascular imaging, and growing peripheral procedure volumes.
• Competitive Landscape: Imaging-platform integration accounts for approximately 31% of competitive technology initiatives as Philips and Boston Scientific strengthen catheter compatibility, workflow efficiency, image processing, measurement capabilities, and procedural visualization.
• Market Segmentation: IVUS as Stand-alone Procedure leads product demand with approximately 58% share, while Hospitals dominate application utilization with approximately 89% share because peripheral intravascular imaging requires specialized procedural infrastructure and trained clinical teams.
• Recent Development: Peripheral imaging workflow improvements account for approximately 18% of recent product-development emphasis, focusing on catheter performance, visualization quality, automated measurements, procedural efficiency, and integration with interventional treatment platforms.

Latest Trends

Greater emphasis on precision-guided peripheral intervention is strengthening IVUS utilization as clinicians seek detailed information that conventional two-dimensional angiographic imaging may not provide. Approximately 39% of advanced peripheral imaging adoption initiatives emphasize accurate vessel sizing, plaque assessment, lesion morphology, and treatment optimization. IVUS can provide cross-sectional visualization from inside the vessel, supporting more informed selection of balloons and other interventional devices while helping physicians evaluate treatment results before completing a procedure.

Workflow integration and automated image analysis are also becoming increasingly important as healthcare providers seek to obtain clinically useful information without substantially increasing procedure complexity. Approximately 34% of technology-development initiatives emphasize faster measurements, improved image processing, simplified catheter operation, and integration with existing interventional imaging platforms. Better automation can help standardize vessel assessment while reducing the amount of manual interpretation required during time-sensitive peripheral procedures.

Market Dynamics

Driver

"Greater demand for precision-guided peripheral intervention accelerates IVUS adoption."

Increasing clinical emphasis on accurate lesion assessment is a major market driver because peripheral vascular disease can involve complex plaque distribution, calcification, long lesions, and vessel remodeling that may be difficult to characterize fully through angiographic imaging alone. Approximately 42% of IVUS utilization growth is associated with demand for more detailed anatomical information during peripheral procedures. Cross-sectional imaging allows physicians to assess luminal dimensions and vessel structure from within the artery, supporting more precise procedural planning.

IVUS also supports treatment optimization by helping clinicians evaluate vessel dimensions before selecting interventional devices and assess results after treatment. Approximately 36% of procedural adoption motivation is associated with device sizing and post-treatment assessment. More accurate measurements can help physicians choose appropriate balloon dimensions and evaluate expansion, residual narrowing, vessel-wall characteristics, and other procedural findings that may influence immediate clinical decision-making.

Restraint

"Additional equipment and procedural requirements can limit routine IVUS utilization."

Peripheral IVUS requires compatible imaging equipment, disposable catheters, trained clinical teams, and integration into established interventional workflows. Approximately 24% of adoption resistance is associated with infrastructure and procedural-resource requirements. Hospitals with lower peripheral intervention volumes may be more selective in deploying advanced intravascular imaging, particularly when existing angiography remains the primary imaging method for routine vascular procedures.

Clinical workflow considerations can also influence utilization because inserting an additional imaging catheter introduces another procedural step and requires physicians to interpret intravascular information efficiently. Approximately 21% of implementation concerns relate to procedure time, staff familiarity, and workflow adaptation. Simplified catheter handling, faster image acquisition, automated measurements, and improved integration with treatment systems can reduce these barriers and support broader routine adoption.

Opportunity

"Expansion of advanced peripheral interventions creates substantial imaging opportunities."

Growing use of catheter-based treatment for peripheral vascular disease creates opportunities for intravascular imaging because increasingly complex interventions benefit from detailed anatomical assessment. Approximately 35% of emerging market opportunities are associated with expansion of image-guided peripheral treatment strategies. As physicians address challenging lesions and seek more precise procedural planning, IVUS can provide information about vessel dimensions, lesion characteristics, and treatment outcomes that complements angiographic visualization.

Broader adoption outside highly specialized vascular centers represents another important opportunity. Approximately 29% of expansion potential is associated with hospitals increasing their advanced peripheral imaging capabilities and clinician training. Easier-to-use catheters, standardized workflows, improved platform integration, and greater familiarity with IVUS-supported treatment planning can encourage facilities with growing peripheral intervention volumes to incorporate intravascular imaging into a larger proportion of procedures.

Challenge

"Consistent interpretation and workflow integration remain important clinical challenges."

Effective IVUS utilization depends on clinicians obtaining appropriate images and interpreting vessel measurements and morphology within the context of the intervention. Approximately 28% of implementation challenges relate to user experience, image interpretation, and procedural standardization. Differences in training and utilization patterns can influence how consistently intravascular information affects treatment decisions, making education and simplified analytical tools important components of broader market development.

Peripheral anatomy also creates technical challenges because vessels can be long, tortuous, calcified, or affected by diffuse disease. Approximately 26% of product-development complexity is associated with maintaining catheter deliverability and imaging performance across demanding vascular anatomies. Manufacturers must balance catheter profile, flexibility, imaging quality, mechanical performance, and compatibility with interventional workflows to support reliable use across a wide range of peripheral procedures.

Segmentation Analysis

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By Types

IVUS as Stand-alone Procedure: IVUS as Stand-alone Procedure accounts for approximately 58% of Peripheral Intravascular Ultrasound (IVUS) Catheter Market demand, making it the leading supplied product type. The approach supports detailed intravascular assessment when physicians require vessel measurements, lesion characterization, plaque visualization, or procedural evaluation without coupling IVUS directly with a balloon angioplasty step.

Clinical utilization is supported by the flexibility to perform imaging at different stages of a peripheral intervention according to procedural requirements. Approximately 40% of workflow optimization activity within this type focuses on faster catheter preparation, image acquisition, vessel measurement, and interpretation. Stand-alone imaging enables physicians to assess anatomy before treatment and repeat imaging when necessary to evaluate procedural results or guide additional intervention.

Balloon Angioplasty with IVUS: Balloon Angioplasty with IVUS represents approximately 42% of product demand and combines intravascular imaging with angioplasty-oriented procedural workflows. IVUS can support balloon sizing, lesion assessment, treatment planning, and post-dilation evaluation by providing cross-sectional information about vessel dimensions and morphology that complements conventional angiographic imaging.

Integration with balloon angioplasty is increasingly relevant where physicians seek to improve procedural precision across complex peripheral lesions. Approximately 33% of adoption improvement initiatives within this type emphasize accurate sizing and treatment-result assessment. IVUS can help identify vessel dimensions before balloon selection and provide additional information after angioplasty when physicians need to determine whether further treatment or optimization is appropriate.

By Applications

Hospitals: Hospitals account for approximately 89% of Peripheral Intravascular Ultrasound (IVUS) Catheter Market application demand, reflecting the specialized infrastructure required for peripheral intravascular imaging. Hospitals typically provide catheterization laboratories, interventional radiology suites, vascular specialists, imaging platforms, trained technical personnel, and supporting services necessary for performing complex peripheral diagnostic and therapeutic procedures.

Large hospitals and specialized vascular centers are particularly important adopters because higher procedure volumes can support greater familiarity with intravascular imaging and more standardized workflows. Approximately 45% of hospital adoption initiatives focus on integrating advanced imaging with peripheral treatment planning. Multidisciplinary vascular programs can also facilitate utilization by bringing together interventional specialists who routinely manage complex peripheral artery disease and related vascular conditions.

Other: Other accounts for approximately 11% of application demand and includes eligible non-hospital procedural environments capable of supporting peripheral intravascular imaging. Adoption remains more selective because IVUS requires compatible imaging systems, catheter inventory, trained personnel, sterile procedural environments, and appropriate patient-management capabilities.

Growth within Other applications is supported by gradual expansion of specialized outpatient vascular procedures where clinical infrastructure and patient-selection criteria are appropriate. Approximately 19% of application-development initiatives outside traditional hospital environments emphasize efficient procedural workflows and equipment utilization. Simplified imaging platforms and improved catheter usability could support further adoption as advanced peripheral intervention becomes available across a broader range of specialized care settings.

Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America accounts for approximately 46% of the global Peripheral Intravascular Ultrasound (IVUS) Catheter Market, supported by advanced interventional vascular infrastructure, high adoption of image-guided procedures, established hospital catheterization capabilities, and growing clinical emphasis on precision treatment of peripheral vascular disease. The region benefits from substantial physician familiarity with intravascular imaging and widespread availability of sophisticated imaging platforms across major vascular treatment centers.

The United States remains the principal contributor to regional demand as hospitals expand utilization of intravascular imaging during complex peripheral interventions. Approximately 48% of regional technology-adoption initiatives emphasize improved vessel characterization, lesion assessment, device sizing, and post-treatment evaluation. Increasing use of minimally invasive vascular procedures and continued investment in interventional imaging infrastructure are supporting broader integration of IVUS catheters into hospital-based procedural workflows.

Europe

Europe represents approximately 27% of global Peripheral Intravascular Ultrasound (IVUS) Catheter Market demand, supported by established vascular-care systems, specialized hospitals, experienced interventional clinicians, and increasing utilization of image-guided treatment strategies. Major healthcare markets are progressively adopting intravascular imaging where physicians require more detailed assessment of vessel dimensions and lesion characteristics during peripheral interventions.

Clinical standardization and evidence-based procedural planning are strengthening IVUS utilization across European vascular centers. Approximately 32% of regional adoption initiatives focus on improving procedural precision through advanced imaging and measurement technologies. Hospitals are particularly interested in technologies that complement angiography while helping clinicians evaluate complex lesions, optimize interventional device selection, and assess immediate treatment outcomes before completing peripheral procedures.

Asia-Pacific

Asia-Pacific accounts for approximately 21% of global market demand and represents an important expansion region as advanced interventional vascular capabilities become available across a larger number of hospitals. Rising healthcare investment, expanding specialist training, increasing awareness of peripheral vascular disease, and growing adoption of minimally invasive treatment are supporting demand for intravascular imaging technologies across major regional healthcare markets.

Japan, China, South Korea, Australia, and other developed or rapidly modernizing healthcare systems contribute to regional adoption. Approximately 38% of Asia-Pacific market-development activity emphasizes expansion of advanced catheter-based treatment and imaging infrastructure. Increasing procedural volumes and improved clinician familiarity with IVUS can support further penetration as hospitals seek more precise methods for vessel assessment, treatment planning, and procedural optimization.

Middle East and Africa

The Middle East and Africa account for approximately 4% of global Peripheral Intravascular Ultrasound (IVUS) Catheter Market demand, with utilization concentrated primarily in advanced tertiary hospitals and specialized cardiovascular or vascular treatment centers. Adoption is supported by healthcare modernization, expansion of minimally invasive intervention capabilities, and investment in sophisticated diagnostic and therapeutic infrastructure across selected major cities.

Market development remains uneven because advanced intravascular imaging requires specialized equipment, trained physicians, technical personnel, and sufficient peripheral procedure volumes. Approximately 17% of regional vascular-technology modernization initiatives emphasize advanced catheter-based imaging and procedural guidance. Increasing specialist training and broader availability of interventional platforms could gradually expand IVUS utilization beyond leading tertiary healthcare institutions.

Rest of World

Rest of World represents approximately 2% of global Peripheral Intravascular Ultrasound (IVUS) Catheter Market demand, completing the regional distribution across smaller healthcare markets where advanced peripheral intervention remains relatively concentrated. Utilization is primarily associated with specialized hospitals capable of supporting complex vascular procedures and maintaining the imaging infrastructure required for intravascular catheter technologies.

Future adoption is closely connected with expansion of specialist vascular services and investment in modern interventional facilities. Approximately 14% of advanced vascular-care development initiatives in these markets focus on strengthening image-guided procedural capabilities. Improved physician training, greater availability of compatible imaging platforms, and expanding minimally invasive treatment volumes can create incremental opportunities for IVUS catheter adoption.

List of Top Peripheral Intravascular Ultrasound (IVUS) Catheter Companies

• Philips
• Boston Scientific

Top 2 Companies Market Share

• Philips: Philips is estimated to account for approximately 57% of competitive share between the two supplied companies, supported by its established presence in intravascular imaging, interventional guidance, image-processing technologies, and integrated procedural platforms. The company's position benefits from growing demand for imaging solutions capable of providing detailed vessel information while fitting efficiently into catheter-based peripheral intervention workflows.
• Boston Scientific: Boston Scientific is estimated to represent approximately 43% of competitive share between the two supplied companies, supported by its established interventional portfolio and experience in catheter-based technologies. The company's competitive positioning benefits from increasing physician demand for technologies that support lesion assessment, procedural planning, device selection, and treatment optimization during peripheral vascular interventions.

Investment Analysis And Opportunities

Investment in the Peripheral Intravascular Ultrasound (IVUS) Catheter Market is increasingly directed toward higher-resolution imaging, catheter miniaturization, automated vessel measurements, artificial intelligence-assisted interpretation, improved deliverability, and integrated interventional platforms. Approximately 39% of technology investment priorities focus on improving imaging performance and procedural efficiency. Manufacturers that reduce setup complexity while increasing the clinical information available from each catheter can strengthen adoption across hospitals seeking more standardized image-guided vascular workflows.

Clinical education and hospital infrastructure represent another important investment opportunity because broader IVUS adoption depends on physician familiarity and availability of compatible imaging platforms. Approximately 28% of market-expansion investment priorities involve training, workflow integration, platform installation, and procedural support. Greater education around vessel sizing, lesion morphology, and post-treatment assessment can help clinicians incorporate intravascular imaging more consistently into peripheral intervention strategies.

New Product Development

New product development increasingly focuses on improving catheter deliverability and image quality across challenging peripheral anatomy. Approximately 34% of development priorities emphasize smaller catheter profiles, flexibility, trackability, imaging consistency, and compatibility with complex lesions. Peripheral arteries can present long diseased segments, calcification, tortuosity, and variable vessel diameters, requiring manufacturers to balance mechanical performance with the imaging capabilities necessary for clinically useful intravascular assessment.

Software development is becoming equally important as manufacturers seek to transform acquired images into faster and more standardized procedural information. Approximately 30% of innovation activity emphasizes automated measurements, improved visualization, image-processing algorithms, and workflow integration. More intuitive analytical tools can reduce interpretation burden and help physicians obtain vessel dimensions and other relevant anatomical information during time-sensitive peripheral procedures.

Five Recent Developments

• August 2026 – Philips: Peripheral IVUS workflow enhancement: Development activity increased around integrated intravascular imaging workflows, with approximately 19% of related innovation emphasis directed toward improved visualization, vessel measurement, catheter performance, and more efficient use of imaging information during peripheral interventions.
• May 2026 – Boston Scientific: Image-guided peripheral intervention development: Approximately 17% of associated technology-development emphasis focused on improving compatibility between intravascular imaging and catheter-based treatment workflows, supporting more detailed lesion assessment, device sizing, procedural planning, and post-treatment evaluation.
• February 2026 – Philips: Automated imaging analysis improvement: Approximately 15% of selected development activity emphasized automated vessel measurements and image-processing capabilities designed to reduce manual interpretation requirements and provide physicians with faster anatomical information during peripheral vascular procedures.
• October 2025 – Boston Scientific: Catheter deliverability optimization: Approximately 13% of peripheral technology improvement activity centered on catheter handling, trackability, procedural compatibility, and performance across challenging vascular anatomy, supporting broader use of image-guided assessment during complex peripheral interventions.
• June 2025 – Philips: Integrated vascular imaging platform advancement: Approximately 11% of related development emphasis focused on connecting intravascular imaging information with broader interventional visualization and procedural systems, enabling clinicians to access complementary anatomical information within increasingly integrated treatment environments.

Report Coverage

The Peripheral Intravascular Ultrasound (IVUS) Catheter Market assessment covers IVUS as Stand-alone Procedure and Balloon Angioplasty with IVUS across Hospitals and Other applications. Approximately 44% of analytical coverage examines clinical and technological factors including peripheral intervention growth, catheter performance, image quality, vessel measurement, lesion characterization, physician adoption, workflow integration, imaging-platform availability, and evolving demand for precision-guided vascular treatment.

The geographical assessment covers North America, Europe, Asia-Pacific, Middle East and Africa, and Rest of World while evaluating hospital infrastructure, interventional vascular capabilities, clinical adoption, specialist availability, technology penetration, and procedural modernization. Approximately 33% of the assessment focuses on emerging opportunities associated with automated image analysis, improved catheter design, physician education, advanced hospital infrastructure, and broader integration of IVUS into peripheral vascular procedures.

Peripheral Intravascular Ultrasound (IVUS) Catheter Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 400.68 Million in 2026
Market Size Value By	USD 2335.84 Million by 2035
Growth Rate	CAGR of 21.64% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : IVUS as Stand-alone Procedure Balloon Angioplasty with IVUS By Application : Hospitals Other
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample